Build your own keyword analysis with our tools
SEO Report
Server Infos
Backlinks

HTML Analysis

Page Status
 

Found

Highlighted Content
Title

Actavis - a global, integrated specialty pharmaceutical company

Description

Actavis, Inc. (NYSE: ACT) is a global, integrated specialty pharmaceutical company focused on developing, manufacturing and distributing generic, brand and biosimilar products.

Keywords

Actavis - a global, integrated specialty pharmaceutical company

H1

We are the New Actavis
A Global Leader in Generics
Aggressively Expanding Global Brands
Building a Foundation in Biosimilars
Enhancing Customer and Shareholder Value
NYSE:ACT
Act One

H2

Recent News
NYSE
Product Database
Commitment to Quality

H3

H4

H5

Text Analysis

Cloud of Keywords from all content
High relevance
 

actavis global arrow

Medium relevance
 

specialty

Low relevance
 

specialty customer shareholder generic copyright database product leader expanding business chilcott foundation dha australia company compliance

Very Low relevance
 
customer shareholder generic copyright database product leader expanding business chilcott foundation dha australia company compliance coverage responsibility fda receives approval alertsanalyst challenge warner patent vimpat® confirms requestse-mail environmentalemployeesfacilities opana® actavisculturebenefitscareer opportunitiesuniversityon-campus working careers profilepress acquisition receive recruitinginternships news releasesresourceswarner contact graduatesapplying corporate programsrecent manufacturingpartnerscommunity genericsaggressively sitemap development stock policy privacy legal disclaimer quote feed data 20-minutes delayed intraday online powered edgar reserved rights servicesfaqsinformation brandsaggressively brandsbuilding genericsa actavisa request actaviswe biosimilarsbuilding biosimilarsenhancing commitment quality nyse actnyse valueenhancing valuenyse ftc presentationsstock switzerland turkey ukraine united kingdom united kingdom slovenia spain sweden sweden portugal romania russia serbia singapore zealand new zealand netherlands norway poland poland profileceo messagemission pharmanorth americaeuropeasia meaactavis pacific locationsfacilitiescommercialamericaseuropeasia cultureexecutive leadershipglobal malta mongolia new japan lithuania luxemburg malaysia ascent spirit austria belgium bosnia websites country integrated pharmaceutical herzegovina bulgaria brazil canada cobalt alet hong kong hungary iceland indonesia ireland ireland germany greece republic denmark finland france canada china czech brandsunited statescanada directorscommittee compositioncommittee charterscode officers governanceexecutive fact sheetcorporate conductgovernance guidelinesinsider charthistorical price lookupinvestment quotestock informationstock transactionsactavis programevents materialscorporate proxy r&dbiosimilars r&dbrands r&dtherapeutic sitesgenerics r&dr&d latambiosimilarsdistributionandapractrxintellogics products classesgenericsbiosimilarsbrandsdrug safetyqualityu filingsannual reportsquarterly results2013 informationsec releasesfinancial investors press calculatorshareholder

Highlighted Content Analysis

Cloud of Keywords from all content
High relevance
 

Medium relevance
 

global actavis nyse

Low relevance
 

actavis nyse specialty integrated company pharmaceutical

Very Low relevance
 
specialty integrated company pharmaceutical customer shareholder foundation news biosimilars enhancing quality actavis - a global integrated specialty pharmaceutical company building commitment database product generics distributing generic manufacturing developing focused brand biosimilar expanding aggressively leader products brands